NeuroPace(NPCE) - 2023 Q4 - Earnings Call Presentation

N UVEI C O RP O RATIO N Shareholder Letter M ARC H 5 , 2024 Fourth Quarter and Full Year 2023 Fourth Quarter 2023 Financial Snapshot Total Combined leverage Revenue Growth Adj. EBITDA Margin(2) Volume(1)Growth ratio(2)(3) 46% 37.3% 53% 2.5x Y/Y +100 bps Q/Q Y/Y (0.1x) Q/Q Total volume(1) (B)Revenue(B) Revenue (M) Growth % Y/Y Growth % Y/Y 321.5321.5 61.8 307.0307.0 304.9 40.340.3 42.4 50.650.6 48.2 220.3220.3 256.5 +28% +45% +68% +72% +53% +4% +20% +45% +55% +46% Q4 Q1 Q2 Q3 Q4 Q4 Q1 Q2 Q3 Q4 2022 2023 2022 2023 Adjusted EBITDA ...